Manus Rogan

12 results

Irish company Mainstay Medical  has developed a device to address chronic lower back pain

Irish company Mainstay Medical, which has developed a device to address chronic lower back pain, has raised $108 million(€89 million) to commercialis(...)

Aidan King, Dr Manus Rogan and Dr Ena Prosser of Fountain Healthcare Partners.  Photograph: Nick Bradshaw

Irish life sciences investor Fountain Healthcare Partners has closed its third fund, having raised €125 million. It brings to just over €300 million t(...)

Neuromod chief executive Ross O’Neill (right) with Manus  Rogan, managing partner at Fountain Healthcare Partners. Photograph: Nick Bradshaw

Irish tinnitus therapy group Neuromod has raised €10.5 million to fund the company’s expansion. Tinnitus is a chronic condition that is understood to(...)

A Dublin company chasing a cure for one of the most common forms of leukaemia has raised €30 million.

Irish life sciences venture capital group Fountain Healthcare Partners has led a €30 million fundraising for a new company hunting for treatment for o(...)

Inflazome chairman Dr Manus Rogan, co-founders Dr Matt Cooper and Prof Luke O’Neill, and Dr Jeremy Skillington, vice-president, business development, photographed in 2016. Photograph: Nick Bradshaw

Swiss drug giant Roche has paid €380 million upfront for a four-year-old Irish biotech company working on treatments to meet clinically unmet needs in(...)

Finlay McFadyen, head of investment banking, AIB Group; Fountain Healthcare partner Dr Manus Rogan; and Andrew McDowell, vice-president, European Investment Bank. Photograph: Nick Bradshaw

Irish life sciences venture capital group Fountain Healthcare Partners has raised €118 million in a new fund. The sum is well in excess of the €100 m(...)

 Inflazome chief executive Prof Matt Cooper  with  co-founder Prof Luke O’Neill (centre) with  Fountain Healthcare Partners managing director Dr Manus Rogan (left) and and  Dr Jeremy Skillington, vice-president of business development at Inflazome. Photograph: Nick Bradshaw

An Irish start-up drug development company that is targeting a series of inflammatory conditions has raised €40 million to fund clinical trials. The (...)

Fountain Healthcare Partners managing director Dr Manus Rogan with Inflazome chief executive Prof Matt Cooper, co-founder Prof Luke O’Neill and business development vice-president Dr Jeremy Skillington. Photograph: Nick Bradshaw

A Dublin start-up chasing a breakthrough treatment for a broad range of inflammatory diseases has raised €15 million to move into clinical trials. (...)

Mainstay Medical chief executive  Peter Crosby estimates that there is a potential market for its device of more than two million people in the US and Europe. Photograph: Nick Bradshaw

Irish company Mainstay Medical will seek regulatory approval in Europe for its chronic lower back pain device following clinical trial results that co(...)

AIB is a significant provider of seed capital funding in Ireland. It has committed €90 million to six funds, which have a combined size of €343 million

AIB has committed €15 million to a dedicated life-sciences venture-capital fund managed by Dublin-based Fountain Healthcare Partners. AIB is investing(...)

  • 1
  • 2
  • Next
  • Last »